Linvoseltamab
Drug timelines are a Plus or Pro feature.
15 regulatory and trial events tracked for Linvoseltamab, covering 2025-09-18 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM) [Phase 3]